Applied Therapeutics, Inc. — Director's Dealing 2021

Apr 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2021-04-14

Reporting Person: MARCUS JOEL S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-14	Common Stock	M	18453	$1.00	Acquired	18453	Indirect
2021-04-14	Common Stock	M	13071	$4.70	Acquired	31524	Indirect
2021-04-14	Common Stock	M	67435	$10.00	Acquired	98959	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-14	Stock Option (Right to Buy)	$1.00	M	18453	Disposed	2027-03-20	Common Stock (18453)	Direct
2021-04-14	Stock Option (Right to Buy)	$4.70	M	35911	Disposed	2029-03-17	Common Stock (35911)	Direct
2021-04-14	Stock Option (Right to Buy)	$10.00	M	13071	Disposed	2029-05-12	Common Stock (13071)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	315360	Direct

Footnotes

F1: Shares held by family trust, of which the reporting person and his spouse are trustees.

F2: These options became fully vested on April 22, 2019.

F3: These options became fully vested on March 18, 2021.

F4: 13,071 shares subject to the options were vested as of April 13, 2021, with one thirty-sixth (1/36th) of the remaining shares subject to the options vesting each month thereafter, subject to the reporting person continuing to provide service through each such date.